Search Results - subject:"PHARMACEUTICAL INDUSTRY"

The maturity of sustainable supply chain management practices : an applied study on pharmaceutical firms

Laghouag, Abderrazak Ahmed - In: Journal of money and business 3 (2023) 2, pp. 237-249

Persistent link: https://www.econbiz.de/10015187514

Improving access to medicines and promoting pharmaceutical innovation

Gamba, Simona (contributor); Magazzini, Laura (contributor); … - European Parliament / Directorate-General for … - 2023

Health is a fundamental human right, and achieving equal access to medicines is crucial to ensuring public health. The current system of pharmaceutical innovation relies strongly on the private sector, and remuneration of innovation is mainly based on exclusivities. This system presents several...

Persistent link: https://www.econbiz.de/10015279627

Syria's pharmaceutical industry : challenges and impacts

Slim, Mada (contributor) - European University Institute - 2023

Before 2011 the Syrian pharmaceutical industry could boast of a distinguished position among those of the Arab nations … Syrian pharmaceutical industry since 2011 can be broadly categorised as caused by domestic or external factors. Domestically … Syrian pharmaceutical industry in the production of illicit drugs, particularly Captagon, the little concrete evidence …

Persistent link: https://www.econbiz.de/10015280589

An analysis of inventory policies for substitute pharmaceuticals with purchasing or selling constraints

Chen, Jingxian; Liang, Liang; Yao, Dong-Qing - In: International transactions in operational research : a … 30 (2023) 1, pp. 572-600

Persistent link: https://www.econbiz.de/10013417044

Practical means of applying the TRIPS Agreement's flexibilities to spur vaccine production

Mitchell, Andrew D.; Taubman, Antony - 2023

Timely and equitable access to vaccines and other health technologies is vital in effectively responding to pandemics and treating other communicable diseases. This paper shows how countries might overcome real or purported intellectual property (IP) barriers to regional COVID-19 vaccine...

Persistent link: https://www.econbiz.de/10013479631

Acquisitions, inventors' turnover, and innovation : evidence from the pharmaceutical industry

Ornaghi, Carmine; Cassi, Lorenzo - 2023

Persistent link: https://www.econbiz.de/10014500480

The imperative of international cooperation for EU competitiveness and resilience in technology-driven industries

Bauer, Matthias; Zilli, Renata; Pandya, Dyuti - 2023

The EU must embrace international cooperation and collaboration in technology-driven industries to ensure competitiveness and global relevance, while also considering the drawbacks of isolationist policies. The EU's commitment to open markets and global cooperation has historically been its...

Persistent link: https://www.econbiz.de/10014440941

Drugs and the Marcos dictatorship : the beginnings of the Philippines' punitive drug regime (1970-1975)

Lasco, Gideon; Yu, Vincen Gregory - In: Journal of illicit economies and development : JIED 5 (2023) 2, pp. 42-53

This article identifies the early dictatorship of former President Ferdinand Marcos as a significant moment in drug policy in the Philippines, as well as the wider Southeast Asian region. Using methods of critical discourse analysis and the notion of episodic history, it shows how the Marcos...

Persistent link: https://www.econbiz.de/10014443201

Resilient drug economy and politicised control : the rise and fall of the administrative bureau of prohibited drugs in China, 1922-1925

Huang, Yun - In: Journal of illicit economies and development : JIED 5 (2023) 2, pp. 54-68

This paper examines the rise and fall of the Administrative Bureau of Prohibited Drugs in 1920s Shanghai. It identifies the factors associated with the endeavours of the central government to experiment with establishing a Bureau dedicated to regulating refined drugs and the reasons why the...

Persistent link: https://www.econbiz.de/10014443202

A note on disease burden and pharmaceutical R&D

Mohan, Vijay; Nabin, Munirul - In: Australian economic papers 62 (2023) 4, pp. 633-649

Persistent link: https://www.econbiz.de/10014443720